Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNA - Episode 3

Data Review: ctDNA Monitoring in Patients with Breast Cancer

Dr. Bardia reviews data from the ASCO 2022 Annual Meeting, focusing on serial postoperative ctDNA monitoring for breast cancer recurrence.

EP. 1: Best Practices for Assessing Risk of Recurrence in Patients with Breast Cancer
EP. 2: Clinical Evidence Supporting the use of ctDNA to Detect Recurrence
Now Viewing
EP. 3: Data Review: ctDNA Monitoring in Patients with Breast Cancer
EP. 4: Practical Clinical Applications for ctDNA Assessment
EP. 5: Technical and Logistical Challenges Concerning the use of ctDNA Monitoring
EP. 6: Promising Strategies for Assessing Risk and Detecting Recurrence Earlier

Related Content:

Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNAOncLive News Network®
Key Takeaways for Concurrent Biomarker Testing in NSCLC
Overcoming Barriers to NSCLC Biomarker Testing
Challenges of NSCLC Biomarker Testing in Clinical Practice